Apollomics (APLM) Assets Average (2023)

Apollomics (APLM) posted quarterly Assets Average of $73.9 million for Q2 2023.

Apollomics (APLM) Assets Average (2023) Analysis & Trends

Apollomics (APLM) has reported Assets Average for 1 consecutive years, with $73.9 million the latest figure, recorded in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets Avg. (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	26.95 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	41.30 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	11.22 Bn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	8.86 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	5.34 Bn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	2.09 Bn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	19.82 Bn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	25.27 Bn
10	Apollomics	34.08 Mn	30.81 Mn	-	-

Download Data

Date	Value
Jun 30, 2023	73.93 Mn